The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Open accessAbstract
Spatial and temporal dissection of the genomic changes occurring during the evolution of human non–small cell lung cancer (NSCLC) may help elucidate the basis for its dismal prognosis. We sequenced 25 spatially distinct regions from seven operable NSCLCs and found evidence of branched evolution, with driver mutations arising before and after subclonal diversification. There was pronounced intratumor heterogeneity in copy number alterations, translocations, and mutations associated with APOBEC cytidine deaminase activity. Despite maintained carcinogen exposure, tumors from smokers showed a relative decrease in smoking-related mutations over time, accompanied by an increase in APOBEC-associated mutations. In tumors from former smokers, genome-doubling occurred within a smoking-signature context before subclonal diversification, which suggested that a long period of tumor latency had preceded clinical detection. The regionally separated driver mutations, coupled with the relentless and heterogeneous nature of the genome instability processes, are likely to confound treatment success in NSCLC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While the full extent to which mutational processes account for unique combinations of somatic genomic alterations in NSCLC is currently unknown, there is evidence that APOBEC-mediated mutagenesis fuels sub-clonal diversification and branched evolution78, 79.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [79]
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Estimating the Dimension of a Model
Schwarz, G. (1978) · The Annals of Statistics · doi:10.1214/aos/1176344136 · Cited by 47,033
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., & Kumar, S. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr121 · Cited by 40,166
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Circos: An information aesthetic for comparative genomicsPreprint
Krzywinski, M. I., Schein, J. E., Birol, İ., Connors, J. M., Gascoyne, R. D., Horsman, D. E., Jones, S. J. M., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 11,073
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citation<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
Flagged first, then by citations
Research works printed but not linked: 1
- Soria J. C., Cruz C., Bahleda R., Delord J. P., Horn L., Herbst R. S., Spigel D., Mokatrin A., Fine G., Gettinger S., Clinical activity, safety and biomarkers of PD-L1 blockade in non-small cell lung cancer (NSCLC). Eur. J. Cancer 49 (suppl. 2), 3408 (2013).
Cited by
Sorted by citations
Items 201–300 of 1,000
Tan, C.-S., Cho, B.-C., & Soo, R. A. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.01.003 · Cited by 105
APOBEC3 genes: retroviral restriction factors to cancer drivers
Henderson, S. R., & Fenton, T. R. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.007 · Cited by 107
Wu, K., Zhang, X., Li, F., Xiao, D., Hou, Y., Zhu, S., Liu, D., Ye, X., Ye, M., Yang, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms10131 · Cited by 109
The bad seed: Cancer stem cells in tumor development and resistance
Koren, E., & Fuchs, Y. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.06.006 · Cited by 112
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going
Russo, A., Franchina, T., Ricciardi, G. R. R., Smiroldo, V., Picciotto, M., Zanghì, M., Rolfo, C. D., & Adamo, V. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.07.003 · Cited by 112
Intratumoral heterogeneity and drug resistance in cancer
Fu, Y.-C., Liang, S.-B., Luo, M., & Wang, X. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03734-w · Cited by 129
Yanagita, M., Redig, A. J., Paweletz, C. P., Dahlberg, S. E., O’Connell, A., Feeney, N. B., Taibi, M., Boucher, D. H., Oxnard, G. R., Johnson, B. E., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0909 · Cited by 109
Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
Joung, J., Oh, B. Y., Hong, H. K., Alkhalidi, H., Al-Alem, F., Lee, H., Bae, J. S., Kim, J.-H., Cha, H., Alotaibi, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0306 · Cited by 108
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
Caswell, D. R., Gui, P., Mayekar, M. K., Law, E. K., Pich, O., Bailey, C., Boumelha, J., Kerr, D. L., Blakely, C. M., Manabe, T., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01592-8 · Cited by 114
Self-citationThe immune response‐related mutational signatures and driver genes in non‐small‐cell lung cancer
Chen, H., Chong, W., Teng, C., Yao, Y., Wang, X., & Li, X. (2019) · Cancer Science · doi:10.1111/cas.14113 · Cited by 106
Circulating Tumor Cells: Fluid Surrogates of Solid Tumors
Thiele, J.-A., Bethel, K., Králíčková, M., & Kuhn, P. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100256 · Cited by 107
Harbst, K., Lauss, M., Cirenajwis, H., Isaksson, K., Rosengren, F., Törngren, T., Kvist, A., Johansson, M. C., Vallon‐Christersson, J., Baldetorp, B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3476 · Cited by 108
MacDonald, W., Purcell, C., Pinho-Schwermann, M. P., Stubbs, N. M., Srinivasan, P. R., & El‐Deiry, W. S. (2025) · Cancers · doi:10.3390/cancers17030441 · Cited by 119
The Ecology and Evolution of Cancer: The Ultra-Microevolutionary Process
Wu, C., Wang, H., Ling, S., & Lu, X. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-112414-054842 · Cited by 106
Nadal, E., Massutí, B., Dómine, M., García‐Campelo, R., Cobo, M., & Felip, E. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02310-2 · Cited by 105
Targeting DNA repair in cancer: current state and novel approaches
Klinakis, A., Karagiannis, D., & Rampias, T. N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03299-8 · Cited by 108
Analysis of cancer genomes reveals basic features of human aging and its role in cancer development
Podolskiy, D. I., Lobanov, A. V., Kryukov, G. V., & Gladyshev, V. N. (2016) · Nature Communications · doi:10.1038/ncomms12157 · Cited by 100
Raynaud, F., Mina, M., Tavernari, D., & Ciriello, G. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007669 · Cited by 106
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomesPreprint
Dentro, S. C., Leshchiner, I., Haase, K., Tarabichi, M., Wintersinger, J. A., Deshwar, A. G., Yu, K., Rubanova, Y., Macintyre, G., Demeulemeester, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/312041 · Cited by 103
Self-citationTumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome
Venkatesan, S., & Swanton, C. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_158930 · Cited by 106
Self-citationSu, Z., Wang, Z., Ni, X., Duan, J., Gao, Y., Zhuo, M., Li, R., Zhao, J., Ma, Q., Bai, H., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3571 · Cited by 103
Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain
Shi, K., Carpenter, M. A., Kurahashi, K., Harris, R. S., & Aihara, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679951 · Cited by 98
Update on the types and usage of liquid biopsies in the clinical setting: a systematic review
Arneth, B. M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4433-3 · Cited by 103
Lung cancer and metastasis: new opportunities and challenges
Wang, X., & Adjei, A. A. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9562-4 · Cited by 98
Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?
Yang, M., Forbes, M. E., Bitting, R. L., O’Neill, S. S., Chou, P. C., Topaloĝlu, Ü., Miller, L. D., Hawkins, G. A., Grant, S. C., DeYoung, B. R., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx766 · Cited by 99
Roper, N., Gao, S., Maity, T. K., Banday, A. R., Zhang, X., Venugopalan, A. K., Cultraro, C. M., Patidar, R., Sindiri, S., Brown, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2019.02.028 · Cited by 97
Genomic mapping of metastatic organotropism in lung adenocarcinoma
Lengel, H. B., Mastrogiacomo, B., Connolly, J. G., Tan, K. S., Liu, Y., Fick, C. N., Dunne, E. G., He, D., Lankadasari, M. B., Satravada, B. A., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.03.018 · Cited by 96
Self-citationKazdal, D. N., Endris, V., Allgäuer, M., Kriegsmann, M., Leichsenring, J., Volckmar, A., Harms, A., Kirchner, M., Kriegsmann, K., Neumann, O., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.07.006 · Cited by 95
Self-citationStructural Variation in Cancer: Role, Prevalence, and Mechanisms
Cosenza, M. R., Rodríguez–Martín, B., & Korbel, J. O. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120121-101149 · Cited by 99
Wang, X., Lamberti, G., Federico, A. D., Alessi, J. V., Ferrara, R., Sholl, M. L., Awad, M. M., Vokes, N. I., & Ricciuti, B. (2024) · Annals of Oncology · doi:10.1016/j.annonc.2024.03.007 · Cited by 99
Liu, Q., Via, L. E., Luò, T., Liang, L., Liu, X., Wu, S.-Y., Shen, Q., Wang, W., Ruan, X., Yuan, X., et al. (2015) · Scientific Reports · doi:10.1038/srep17507 · Cited by 95
Hoadley, K. A., Siegel, M. B., Kanchi, K., Miller, C. A., Ding, L., Wei, Z., He, X., Parker, J. S., Wendl, M. C., Fulton, R. S., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002174 · Cited by 97
Sohoni, S. S., Ghosh, P., Wang, T., Kalainayakan, S. P., Vidal, C., Dey, S., Konduri, P. C., & Li, Z. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2156 · Cited by 95
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
Findlay, J. M., Castro-Giner, F., Makino, S., Rayner, E., Kartsonaki, C., Cross, W. C. H., Kovac, M. B., Ulahannan, D., Palles, C., Gillies, R. S., et al. (2016) · Nature Communications · doi:10.1038/ncomms11111 · Cited by 97
Lamy, P., Nordentoft, I., Birkenkamp‐Demtröder, K., Thomsen, M. B. H., Villesen, P., Vang, S., Hedegaard, J., Borre, M., Jensen, J. B., Høyer, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0436 · Cited by 93
Wang, W., Song, Z., & Zhang, Y. (2016) · Cancer Medicine · doi:10.1002/cam4.978 · Cited by 94
Ashley, C. W., Paula, A. D. C., Kumar, R., Mandelker, D. L., Pei, X., Riaz, N., Reis-Filho, J. S., & Weigelt, B. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.032 · Cited by 94
DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers
Mas-Ponte, D., & Supek, F. (2020) · Nature Genetics · doi:10.1038/s41588-020-0674-6 · Cited by 97
The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments
Capua, D. D., Bracken-Clarke, D. M., Ronan, K. E., Baird, A., & Finn, S. P. (2021) · Cancers · doi:10.3390/cancers13163923 · Cited by 98
Choi, E.-R., Lee, H. Y., Jeong, J. Y., Choi, Y., Kim, J., Bae, J., Lee, K. S., & Shim, Y. M. (2016) · Oncotarget · doi:10.18632/oncotarget.11693 · Cited by 91
APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma
Cannataro, V. L., Gaffney, S. G., Sasaki, T., Issaeva, N., Grewal, N., Grandis, J. R., Yarbrough, W. G., Burtness, B. A., Anderson, K. S., & Townsend, J. P. (2019) · Oncogene · doi:10.1038/s41388-018-0657-6 · Cited by 93
Mansuet‐Lupo, A., Barritault, M., Alifano, M., Janet-Vendroux, A., Zarmaev, M., Biton, J., Velut, Y., Hay, C. L., Cremer, I., Régnard, J., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.01.017 · Cited by 92
Timing and Origins of Local and Distant Metastases in Lung Cancer
Tang, W., Wu, M., Bao, H., Xu, Y., Lin, J., Liang, Y., Zhang, Y., Chu, X., Qiu, Z., Su, J., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.02.023 · Cited by 89
A gene set enrichment analysis for cancer hallmarks
Menyhárt, O., Kothalawala, W. J., & Győrffy, B. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101065 · Cited by 92
The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis
Saito, A., Horie, M., Micke, P., & Nagase, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113611 · Cited by 94
Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity
Shi, W., Ng, C. K. Y., Lim, R. S., Jiang, T., Kumar, S., Li, X., Wali, V. B., Piscuoglio, S., Gerstein, M., Chagpar, A. B., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.046 · Cited by 92
A community effort to create standards for evaluating tumor subclonal reconstruction
Participants, D. S.-H., Salcedo, A., Tarabichi, M., Espiritu, S. M. G., Deshwar, A. G., David, M., Wilson, N. M., Dentro, S. C., Wintersinger, J. A., Liu, L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0364-z · Cited by 84
Self-citationThe Role of the ECM in Lung Cancer Dormancy and Outgrowth
Parker, A. L., & Cox, T. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01766 · Cited by 95
The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization
Bohn, M., Shandilya, S. M. D., Silvas, T. V., Nalivaika, E. A., Kouno, T., Kelch, B. A., Ryder, S. P., Yılmaz, N. K., Somasundaran, M., & Schiffer, C. A. (2015) · Structure · doi:10.1016/j.str.2015.03.016 · Cited by 89
Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution
Shlyakhtina, Y., Moran, K. L., & Portal, M. M. (2021) · Cancers · doi:10.3390/cancers13061380 · Cited by 91
Alam, M. M., Lal, S., FitzGerald, K. E., & Li, Z. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0082-9 · Cited by 92
Translating insights into tumor evolution to clinical practice: promises and challenges
Fittall, M. W., & Loo, P. V. (2019) · Genome Medicine · doi:10.1186/s13073-019-0632-z · Cited by 91
Ma, F., Guan, Y., Yi, Z., Chang, L., Li, Q., Chen, S., Zhu, W., Guan, X., Li, C., Qian, H., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32536 · Cited by 88
Self-citationSong, W., Yu, X., Guo, D.-J., Liu, H., Tang, Z.-Y., Liu, X., Zhou, J., Zhang, H.-P., Liu, Y.-Y., & Liu, X. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26977 · Cited by 81
Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications
Cresswell, G. D., Apps, J. R., Chagtai, T., Mifsud, B., Bentley, C. C., Maschietto, M. C., Popov, S. D., Weeks, M. E., Olsen, Ø. E., Sebire, N. J., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.05.029 · Cited by 85
Liquid biopsy of circulating tumor DNA and biosensor applications
Li, X., Ye, M., Zhang, W., Tan, D., Jaffrezic-Renault, N. J., Yang, X., & Guo, Z. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.11.037 · Cited by 88
Cancer classification in the genomic era: five contemporary problems
Song, Q., Merajver, S. D., & Li, J. Z. (2015) · Human Genomics · doi:10.1186/s40246-015-0049-8 · Cited by 92
Intratumor heterogeneity predicts metastasis of triple-negative breast cancer
Yang, F., Wang, Y., Li, Q., Cao, L., Sun, Z., Jin, J., Fang, H., Zhu, A., Li, Y., Zhang, W., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx071 · Cited by 86
Base changes in tumour DNA have the power to reveal the causes and evolution of cancer
Hollstein, M. C., Alexandrov, L. B., Wild, C. P., Ardin, M., & Zavadil, J. (2016) · Oncogene · doi:10.1038/onc.2016.192 · Cited by 85
Contraction of T cell richness in lung cancer brain metastases
Mansfield, A. S., Ren, H., Sutor, S. L., Sarangi, V., Nair, A., Davila, J. I., Elsbernd, L. R., Udell, J. B. M., Dronca, R. S., Park, S. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20622-8 · Cited by 86
Epithelial–Mesenchymal Transition in Non Small-cell Lung Cancer
Tsoukalas, N., Aravantinou-Fatorou, E., Tolia, M., Giaginis, C., Galanopoulos, M., Kiakou, M., Kostakis, I. D., Dana, E., Vamvakaris, I. N., Korogiannos, A., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11510 · Cited by 84
Single cell analysis of clonal architecture in acute myeloid leukaemia
Potter, N. E., Miraki‐Moud, F., Ermini, L., Titley, I., Vijayaraghavan, G., Papaemmanuil, E., Campbell, P. J., Gribben, J. G., Taussig, D. C., & Greaves, M. F. (2018) · Leukemia · doi:10.1038/s41375-018-0319-2 · Cited by 92
Self-citationRethinking the Relationship between Insulin and Cancer
Vigneri, R., Sciacca, L., & Vigneri, P. G. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.05.004 · Cited by 90
Normal tissue architecture determines the evolutionary course of cancer
West, J., Schenck, R. O., Gatenbee, C., Robertson‐Tessi, M., & Anderson, A. R. A. (2021) · Nature Communications · doi:10.1038/s41467-021-22123-1 · Cited by 84
Boumelha, J., Trécesson, S. D. C., Law, E. K., Romero-Clavijo, P., Coelho, M. A., Ng, K. W., Mugarza, E., Moore, C., Rana, S., Caswell, D. R., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0325 · Cited by 84
Self-citationTiming somatic events in the evolution of cancer
Jolly, C., & Loo, P. V. (2018) · Genome biology · doi:10.1186/s13059-018-1476-3 · Cited by 86
Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy
Ascierto, M. L., Makohon-Moore, A. P., Lipson, E. J., Taube, J. M., McMiller, T. L., Berger, A. E., Fan, J., Kaunitz, G. J., Cottrell, T. R., Kohutek, Z. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0270 · Cited by 84
Li, C., Qin, F., Hu, F., Xu, H., Sun, G., Han, G., Wang, T., & Guo, M. (2018) · Cell & Bioscience · doi:10.1186/s13578-018-0202-x · Cited by 81
Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche
Boesch, M., Sopper, S., Zeimet, A. G., Reimer, D., Gastl, G. A., Ludewig, B., & Wolf, D. G. F. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.003 · Cited by 81
Periyasamy, M., Singh, A. K., Gemma, C., Kranjec, C., Farzan, R. A., Leach, D. A., Navaratnam, N., Pálinkás, H. L., Vértessy, B. G., Fenton, T. R., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx721 · Cited by 79
CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
Liu, B., Saber, A., & Haisma, H. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.02.011 · Cited by 86
Ebisudani, T., Hamamoto, J., Togasaki, K., Mitsuishi, A., Sugihara, K., Shinozaki, T., Fukushima, T., Kawasaki, K., Seino, T., Oda, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112212 · Cited by 81
Li, Y., Li, X., Li, H., Zhao, Y., Liu, Z., Sun, K., Zhu, X., Qi, Q., An, B., Shen, D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01409-2019 · Cited by 78
Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma
Flynt, E., Bisht, K. K., Sridharan, V., Ortiz, M., Towfic, F., & Thakurta, A. (2020) · Cells · doi:10.3390/cells9020287 · Cited by 79
Driscoll, C. B., Schuelke, M. R., Kottke, T. J., Thompson, J., Wongthida, P., Tonne, J. M., Huff, A. L., Miller, A. C., Shim, K. G., Molan, A. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14568-7 · Cited by 78
Understanding Drug Sensitivity and Tackling Resistance in Cancer
Tyner, J. W., Haderk, F., Kumaraswamy, A., Baughn, L. B., Ness, B. V., Liu, S., Marathe, H., Alumkal, J. J., Bivona, T. G., Chan, K. S., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3695 · Cited by 81
Hoefflin, R., Lahrmann, B., Warsow, G., Hübschmann, D., Spath, C., Walter, B., Chen, X., Hofer, L., Macher‐Goeppinger, S., Tolstov, Y. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms11845 · Cited by 75
Ma, P., Fu, Y., Cai, M., Yan, Y., Jing, Y., Zhang, S., Chen, M., Wu, J., Shen, Y., Zhu, L. W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00963-0 · Cited by 75
Are liquid biopsies a surrogate for tissue EGFR testing?
Goldman, J. W., Noor, Z. S., Remón, J., Besse, B., & Rosenfeld, N. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx706 · Cited by 77
Measuring Clonal Evolution in Cancer with Genomics
Williams, M. J., Sottoriva, A., & Graham, T. A. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021712 · Cited by 83
Song, X., Xiong, A., Wu, F., Li, X., Wang, J., Jiang, T., Chen, P., Zhang, X., Zhao, Z., Liu, H., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006234 · Cited by 78
Lee, W.-C., Diao, L., Wang, J., Zhang, J., Roarty, E. B., Varghese, S., Chow, C.-W. B., Fujimoto, J., Behrens, C., Cascone, T., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0029-3 · Cited by 73
Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer
Ma, D., Jiang, Y., Liu, X., Liu, Y., & Shao, Z. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4113-z · Cited by 74
Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology
Sasaki, N., & Clevers, H. C. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.09.001 · Cited by 75
Clinical utility of whole-genome sequencing in precision oncology
Rosenquist, R., Cuppen, E. P. J. G., Buettner, R., Caldas, C., Dreau, H. M.-P., Elemento, O., Frederix, G., Grimmond, S. M., Haferlach, T., Jobanputra, V., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.018 · Cited by 73
Cancer prevention with rapamycin
Blagosklonny, M. V. (2023) · Oncotarget · doi:10.18632/oncotarget.28410 · Cited by 74
Application of single-cell genomics in cancer: promise and challenges
Wills, Q. F., & Mead, A. J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv235 · Cited by 77
Molecular origins of APOBEC-associated mutations in cancer
Petljak, M., & Maciejowski, J. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102905 · Cited by 76
Woodcock, D. J., Рябченко, Е. В., Taavitsainen, S., Kankainen, M., Gundem, G., Brewer, D. S., Ellonen, P., Lepistö, M., Golubeva, Y. A., Warner, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18843-5 · Cited by 71
Self-citationUnderstanding EGFR heterogeneity in lung cancer
Passaro, A., Malapelle, U., Re, M. D., Attili, I., Russo, A., Guerini‐Rocco, E., Fumagalli, C., Pisapia, P., Pepe, F., Luca, C. D., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000919 · Cited by 75
Genome Sequencing during a Patient’s Journey through Cancer
Nangalia, J., & Campbell, P. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1910138 · Cited by 66
Self-citationvon Loga, K., Woolston, A., Punta, M., Barber, L. J., Griffiths, B. L., Semiannikova, M., Spain, G., Challoner, B. R., Fenwick, K., Simon, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13915-7 · Cited by 74
Self-citationmiR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop
Shi, L., Wang, Y., Lü, Z., Zhang, H., Zhuang, N., Wang, B., Song, Z., Chen, G., Huang, C., Xu, D., et al. (2016) · Oncogene · doi:10.1038/onc.2016.332 · Cited by 71
Arshad, M., Thornton, A., Lu, H., Tam, H., Wallitt, K. L., Rodgers, N., Scarsbrook, A. F., McDermott, G. M., Cook, G., Landau, D., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4139-4 · Cited by 71
Biological and Medical Importance of Cellular Heterogeneity Deciphered by Single-Cell RNA Sequencing
Gupta, R. K., & Kuźnicki, J. (2020) · Cells · doi:10.3390/cells9081751 · Cited by 74
Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers
Miller, C. A., Gindin, Y., Lu, C., Griffith, O. L., Griffith, M., Shen, D., Hoog, J., Li, T., Larson, D. E., Watson, M. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms12498 · Cited by 69
Potapova, T., Seidel, C. W., Box, A., Rancati, G. I., & Li, R. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-05-0268 · Cited by 68
Wiesweg, M., Eberhardt, W., Reis, H., Ting, S. C., Savvidou, N., Skiba, C., Herold, T., Christoph, D. C., Meiler, J., Worm, K., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.08.137 · Cited by 69
Lung Cancer Heterogeneity and New Strategies for Drug Therapy
Wang, D. C., Wang, W. Y., Zhu, B., & Wang, X. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104523 · Cited by 69
Baslan, T., Kendall, J., Volyanskyy, K. Y., McNamara, K. L., Cox, H., D'Italia, S., Ambrosio, F. J., Riggs, M. G., Rodgers, L., Leotta, A., et al. (2020) · eLife · doi:10.7554/elife.51480 · Cited by 67
Metadata
- Authors
- de Bruin, E. C., McGranahan, N., Mitter, R., Salm, M., Wedge, D. C., Yates, L., Jamal-Hanjani, M., Shafi, S., Murugaesu, N., Rowan, A. J., Grönroos, E., Muhammad, M. A., Horswell, S., Gerlinger, M., Varela, I., Jones, D., Marshall, J., Voet, T., Van Loo, P., Rassl, D. M., Rintoul, R. C., Janes, S. M., Lee, S.-M., Forster, M., Ahmad, T., Lawrence, D., Falzon, M., Capitanio, A., Harkins, T. T., Lee, C. C., Tom, W., Teefe, E., Chen, S.-C., Begum, S., Rabinowitz, A., Phillimore, B., Spencer-Dene, B., Stamp, G., Szallasi, Z., Matthews, N., Stewart, A., Campbell, P., & Swanton, C.
- Affiliations
- Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6BT, UK.
- Cancer Research UK (GB)
- Wellcome Sanger Institute (GB)
- University of Cambridge (GB)
- Cancer Research UK London Research Institute, London WC2A 3LY, UK.
- Universidad de Cantabria (ES)
- Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK.
- Papworth Hospital NHS Foundation Trust (GB)
- University College London (GB)
- Thermo Fisher Scientific (United States) (US)
- Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
- Corresponding author
- McGranahan, Nicholas
- Mitter, Richard
- Salm, Max
- Wedge, David C.
- Yates, Lucy
- Swanton, Charles
- ORCID
- McGranahan, Nicholas
- Mitter, Richard
- Salm, Max
- Wedge, David C.
- Yates, Lucy
- Murugaesu, Nirupa
- Rowan, Andrew J.
- Horswell, Stuart
- Gerlinger, Marco
- Varela, Ignacio
- Jones, David
- Voet, Thierry
- Rassl, Doris M.
- Rintoul, Robert C.
- Janes, Sam M.
- Lee, Siow-Ming
- Forster, Martin
- Lawrence, David
- Falzon, Mary
- Capitanio, Arrigo
- Harkins, Timothy T.
- Lee, Clarence C.
- Teefe, Enock
- Begum, Sharmin
- Rabinowitz, Adam
- Stamp, Gordon
- Matthews, Nik
- Campbell, Peter
- Swanton, Charles
- Venue
- Science
- Published
- 2014-10-10
- Volume
- 346
- Issue
- 6206
- Pages
- 251-256
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2108371618
- Cited by
- 1,117
- References
- 62
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 59 · 2023: 82 · 2022: 82 · 2021: 86 · 2020: 99 · 2019: 113 · 2018: 111 · 2017: 145 · 2016: 131 · 2015: 119 · 2014: 9
- FWCI
- 43.17
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- UCrea (University of Cantabria) (acceptedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Prostate Cancer Foundation
- Breast Cancer Research Foundation
- Wellcome Trust (091730, 105104, 088340)
- Cancer Research UK (259303, A11590, A4688, A17786, 17001, A19310, 17786, 18377)
- National Institute for Health and Care Research (CL-2011-18-001)
- Academy of Medical Sciences (AMS-SGCL7-Murugaesu)
- University College London
- European Commission (259303)
- Rosetrees Trust (M35-F1-CD1)
- Fonds Wetenschappelijk Onderzoek
- Ministerio de Economía y Competitividad
- Vlaamse regering
- National Institutes of Health
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- non-small cell lung cancer, tumor evolution, intratumoral heterogeneity, driver mutations, copy number alterations, chromosomal translocation, APOBEC mutational signature, genome doubling, tumor latency, carcinogen exposure, genomic instability
- MeSH terms
- APOBEC-1 Deaminase, Carcinogens, Carcinoma, Non-Small-Cell Lung, Cytidine Deaminase, Humans, Lung Neoplasms, Mutation, Neoplasm Recurrence, Local, Prognosis, Smoking, Translocation, Genetic, Tumor Cells, Cultured, Gene Dosage, Genetic Heterogeneity, Evolution, Molecular, Genomic Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
